$15,000 of AXOGEN CORPORATION lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"issues related to development of medical products"
You can find more data on corporate lobbying on Quiver Quantitative.
AXGN Insider Trading Activity
AXGN insiders have traded $AXGN stock on the open market 36 times in the past 6 months. Of those trades, 0 have been purchases and 36 have been sales.
Here’s a breakdown of recent trading of $AXGN stock by insiders over the last 6 months:
- WILLIAM P. MR. BURKE has made 0 purchases and 13 sales selling 132,463 shares for an estimated $2,821,444.
- MICHAEL D DALE (Chief Executive Officer) has made 0 purchases and 2 sales selling 86,463 shares for an estimated $2,668,137.
- JOHN JOHNSON has made 0 purchases and 4 sales selling 45,379 shares for an estimated $1,390,392.
- KATHY JOHNSON WEILER has made 0 purchases and 3 sales selling 46,653 shares for an estimated $1,378,475.
- AMY MCBRIDE WENDELL has made 0 purchases and 3 sales selling 43,684 shares for an estimated $1,280,465.
- LINDSEY MARIE HARTLEY (CFO) has made 0 purchases and 3 sales selling 29,199 shares for an estimated $896,298.
- JOSEPH A. TYNDALL has made 0 purchases and 2 sales selling 25,108 shares for an estimated $777,770.
- MARC A BEGAN (EVP & General Counsel) has made 0 purchases and 2 sales selling 22,500 shares for an estimated $686,207.
- PAUL THOMAS sold 21,399 shares for an estimated $633,709
- ERICK WAYNE DEVINNEY (Chief Innovation Officer) has made 0 purchases and 2 sales selling 20,654 shares for an estimated $627,608.
- JENS KEMP (Chief Marketing Officer) sold 8,156 shares for an estimated $254,532
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AXGN Hedge Fund Activity
We have seen 115 institutional investors add shares of AXGN stock to their portfolio, and 92 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FIRST LIGHT ASSET MANAGEMENT, LLC added 1,276,487 shares (+28.2%) to their portfolio in Q3 2025, for an estimated $22,772,528
- WASATCH ADVISORS LP removed 715,779 shares (-43.7%) from their portfolio in Q4 2025, for an estimated $23,427,446
- BROWN CAPITAL MANAGEMENT LLC added 644,623 shares (+inf%) to their portfolio in Q3 2025, for an estimated $11,500,074
- BALYASNY ASSET MANAGEMENT L.P. removed 551,516 shares (-28.6%) from their portfolio in Q3 2025, for an estimated $9,839,045
- QUBE RESEARCH & TECHNOLOGIES LTD removed 545,153 shares (-74.8%) from their portfolio in Q3 2025, for an estimated $9,725,529
- SOLEUS CAPITAL MANAGEMENT, L.P. removed 519,698 shares (-30.1%) from their portfolio in Q4 2025, for an estimated $17,009,715
- MARSHALL WACE, LLP removed 454,126 shares (-70.8%) from their portfolio in Q3 2025, for an estimated $8,101,607
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AXGN Analyst Ratings
Wall Street analysts have issued reports on $AXGN in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 12/05/2025
- Mizuho issued a "Outperform" rating on 12/01/2025
- Canaccord Genuity issued a "Buy" rating on 10/30/2025
- Citizens issued a "Market Outperform" rating on 10/30/2025
- Raymond James issued a "Outperform" rating on 10/30/2025
To track analyst ratings and price targets for AXGN, check out Quiver Quantitative's $AXGN forecast page.
AXGN Price Targets
Multiple analysts have issued price targets for $AXGN recently. We have seen 7 analysts offer price targets for $AXGN in the last 6 months, with a median target of $37.0.
Here are some recent targets:
- Caitlin Cronin from Canaccord Genuity set a target price of $37.0 on 12/05/2025
- Yi Chen from HC Wainwright & Co. set a target price of $39.0 on 12/05/2025
- Frank Takkinen from Lake Street set a target price of $40.0 on 12/04/2025
- Michael Sarcone from Jefferies set a target price of $36.0 on 12/04/2025
- Anthony Petrone from Mizuho set a target price of $40.0 on 12/01/2025
- David Turkaly from Citizens set a target price of $34.0 on 10/30/2025
- Jayson Bedford from Raymond James set a target price of $27.0 on 10/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
